Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134030) titled 'Clinical Study on Romiplostim N01 Promoting Platelet Engraftment After Transplantation' on Oct. 10.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College.
Condition:
Pediatric malignant hematologic diseases
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-15
Target Sample Size: Intervention group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=343841
Disclaimer: Curated by HT Synd...